HMD

HERAMED FPO [HMD]
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.
Healthcare · ASX Small Cap
$0.0340 -8.1%

Updated 9 Sep 2026 · Signals refresh every scan

⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when HMD triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track HMD — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
  • Drifting lower — down 5.6% over the last 5 days
  • Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
  • Low cash runway (4 quarters) - dilution risk
  • 4C filed 2026-07-31
  • Very high P/S ratio (126.2x)
  • Revenue in sharp decline (-72%)
  • Small-cap ($20-100M)
  • Sentiment is mixed — no strong consensus either way
  • The bigger volume days are the up days — volume-weighted momentum is positive (0.82%/day)
  • Altman Z-Score distress zone (1.64 < 1.81, low-confidence approx)
  • Low-priced stock risk ($0.036)
  • RBA hiking (-3pts)

Risk Signals

  • MACD crossed bearish — momentum is fading
  • Trading below both moving averages — the trend is working against this one
  • Broke below 20-day support — that's a level the market was defending, and it just gave way
  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -72% — the top line is shrinking

Expected next for HMD

30 Oct 2026Quarterly Activities ReportEstimated from past filings
Window: 23 Oct to 6 Nov
The last 7 moved HMD +3.1% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →

Recent Catalysts

NONE Notification regarding unquoted securities - HMD
NONE Appendix 4D and Half Year Report
NONE Resignation and Appointment of Joint Company Secretary

Recent ASX Announcements

2026-09-01 Notification regarding unquoted securities - HMD
2026-08-28 Appendix 4D and Half Year Report PRICE SENSITIVE
2026-07-31 Resignation and Appointment of Joint Company Secretary
2026-07-31 Quarterly Activities & Cashflow Report PRICE SENSITIVE
2026-07-24 Change of Director's Interest Notice - TC

Key Metrics

$41.7M
Market Cap
260K
Avg Volume
0.9x
Vol Ratio
$0.03 — $0.06
52-Week Range
N/A
Short Interest
4 qtrs
Cash Runway
-223.7%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 70%
LLeader vs LaggardlaggardRS: -5
IInstitutional SponsorshipweakInst: 3%
MMarket DirectionneutralNeutral

Sector: Healthcare

110 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
NUZ +37.1%IPD +20.0%HIQ +16.7%AVE +15.0%CVB +11.1%
Compare:HMD vs NUZHMD vs IPDHMD vs HIQ
Share this analysis

Track HMD and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required